Grant: Project Grant
McMaster University
$1,147,501.00
Fluids in Septic Shock (FISSH): a randomized controlled trial.
FY 2019-20
Summary
Severe infection can lead to many complications within the human body including low blood pressure, which is called septic shock. Rates of death for those with septic shock can be as high as 40%. The main treatments for septic shock are intravenous antibiotics and intravenous (IV) fluids.
There are many different intravenous fluids available for doctors to use. Each one of these fluids has potential advantages as well as potential disadvantages. Some preliminary and limited research in the field has suggested that one specific electrolyte, called chloride, may be harmful when given to patients in high concentrations. Some intravenous fluids have higher concentrations of chloride than others.
One high chloride fluid, called Normal Saline, remains the most widely used intravenous fluid worldwide. It is unlikely that clinical practice will change until a large-scale study examining outcomes that are important to patients is performed. The investigators plan to study the impact of giving patients with septic shock intravenous fluids with either a high chloride concentration or a low chloride concentration. If there is benefit seen using low chloride concentration fluids this would be easy to initiate across the world leading to a dramatic and relatively inexpensive improvement in patient care.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
408305
Name
Rochwerg Bram N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Randomized Controlled Trials 2
Projecttitle
Fluids in Septic Shock (FISSH): a randomized controlled trial.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$1,147,501
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Fluids; Randomized Controlled Trial; Resuscitation; Sepsis; Shock
Abstract
Severe infection can lead to many complications within the human body including low blood pressure, which is called septic shock. Rates of death for those with septic shock can be as high as 40%. The main treatments for septic shock are intravenous antibiotics and intravenous (IV) fluids.
There are many different intravenous fluids available for doctors to use. Each one of these fluids has potential advantages as well as potential disadvantages. Some preliminary and limited research in the field has suggested that one specific electrolyte, called chloride, may be harmful when given to patients in high concentrations. Some intravenous fluids have higher concentrations of chloride than others.
One high chloride fluid, called Normal Saline, remains the most widely used intravenous fluid worldwide. It is unlikely that clinical practice will change until a large-scale study examining outcomes that are important to patients is performed. The investigators plan to study the impact of giving patients with septic shock intravenous fluids with either a high chloride concentration or a low chloride concentration. If there is benefit seen using low chloride concentration fluids this would be easy to initiate across the world leading to a dramatic and relatively inexpensive improvement in patient care.
Competitiondate
201909
Approvedterm2
3 yrs 6 mths
Pinamesdelim
Rochwerg, Bram N
Approvedterm
3 ans 6 mois
Cihrcontribution2
~ $1,147,501~ $0~